---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-027994"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:24:33.604087+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Roivant subsidiary Dermavant renegotiates debt, reduces potential payments by over $300M

## Summary
- Dermavant caps RIPSA royalties at $6M/yr for FY2025-2027, reducing near-term cash outflow.
- Credit Agreement maturity extended to May 2028; interest rate increased to 12.25% from 10%.
- NovaQuest fixed quarterly payments of $176.3M eliminated; up to $141M in commercial milestones also eliminated.
- Roivant commits $195M in convertible preferred equity at 1.5x liquidation preference; DSL issues ~13.2% common shares to lenders.
- Post-closing, Roivant owns ~87% of DSL common/preferred (~82% fully diluted).

## SEC filing metadata
- accession: 0001140361-24-027994
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000114036124027994/0001140361-24-027994-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000114036124027994/ef20030253_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-027994
- JSON: https://secwatch.observer/filing/0001140361-24-027994.json
- Plain text: https://secwatch.observer/filing/0001140361-24-027994.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.